p27(Kip1) and cyclin E expression and breast cancer survival after treatment with adjuvant chemotherapy. [electronic resource]
Producer: 20070123Description: 1723-31 p. digitalISSN:- 1460-2105
- Antineoplastic Combined Chemotherapy Protocols -- therapeutic use
- Breast Neoplasms -- drug therapy
- Chemotherapy, Adjuvant
- Cyclin E -- genetics
- Cyclin-Dependent Kinase Inhibitor p27 -- genetics
- Cyclophosphamide -- administration & dosage
- Disease-Free Survival
- Doxorubicin -- administration & dosage
- Drug Administration Schedule
- Female
- Gene Expression Regulation, Neoplastic
- Humans
- Survival Analysis
No physical items for this record
Publication Type: Controlled Clinical Trial; Journal Article; Multicenter Study; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.